# India Central Venous Catheter Market

> India Central Venous Catheter Market Research Report: Size, Share, Trend Analysis By Product Type (Non-tunneled Catheters, Tunneled Catheters), By Property (Non-Antimicrobial Catheters, Antimicrobial Catheters, Others), By Design (Multi Lumen, Double Lumen, Single Lumen) and By Composition (Polyurethane, Silicone, Others) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 7.41%
- **2024:** $ 66.91 Million
- **2035:** $ 146.93 Million
- **Key Players:** Bard (US), Medtronic (US), Boston Scientific (US), Teleflex (US), Smiths Medical (US), Vygon (FR), Nipro (JP), Fresenius Kabi (DE), Cook Medical (US)

**Report ID:** MRFR/MED/50717-HCR · **Pages:** 200 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** February 10, 2026

**URL:** https://www.marketresearchfuture.com/reports/india-central-venous-catheter-market-52475

---

## Market Summary

## **India Central Venous Catheter Market Overview**

As per MRFR analysis, the India Central Venous Catheter Market Size was estimated at 95.17 (USD Million) in 2023. The India Central Venous Catheter Market Industry is expected to grow from 100.5(USD Million) in 2024 to 194.5 (USD Million) by 2035. The India Central Venous Catheter Market CAGR (growth rate) is expected to be around 6.186% during the forecast period (2025 - 2035).

**Key India Central Venous Catheter Market Trends Highlighted**

The India Central Venous Catheter market is witnessing significant developments driven by a growing demand for advanced healthcare solutions. One of the key market drivers is the increasing prevalence of chronic diseases, which necessitates better healthcare delivery methods. The rapid urbanization and rising disposable incomes in India are also contributing to a higher demand for quality healthcare infrastructure. Furthermore, the government's initiatives to enhance healthcare facilities, such as the National Health Mission, are pushing hospitals to upgrade their medical technologies, thus expanding the market for central venous catheters. 

In recent times, there has been a shift towards the adoption of safety-engineered devices, which minimize the risk of needlestick injuries, enhancing patient safety and compliance with healthcare regulations.The demand for central venous catheters is also being influenced by the increase in outpatient procedures, as they are frequently employed in ambulatory settings to administer fluids and medications. The market offers a plethora of opportunities for exploration, particularly in the development of infection-resistant catheter technologies and the introduction of telemedicine services for patient monitoring. 

Furthermore, the utilization of central venous catheters in clinical contexts is expanding due to the increasing awareness among healthcare professionals of their advantages. The market is also observing a trend toward localized manufacturers, which can help reduce costs while assuring quality, thereby opening doors for export opportunities. Consequently, the Central Venous Catheter market in India is on the brink of expansion, with an emphasis on innovation and enhanced healthcare outcomes.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**India Central Venous Catheter Market Drivers**

**Rising Incidence of Chronic Diseases**

The increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular diseases in India significantly drives the growth of the India Central Venous Catheter Market Industry. According to the Indian Council of Medical Research, the number of cancer cases is projected to rise to around 1.6 million by 2026, marking an increase from 1.3 million in 2020. 

This growing patient population creates a higher demand for central venous catheters for long-term treatments and therapies.Leading healthcare institutions and organizations, such as the All India Institute of Medical Sciences, are adapting to these rising figures by enhancing their oncology and chronic disease management programs, thereby driving the utilization of central venous catheters.

**Advancements in Medical Technology**

Innovations in medical technology, including the development of more efficient and safer central venous catheters, are propelling the India Central Venous Catheter Market Industry forward. The Indian government's initiatives to promote Research and Development are fostering an environment for innovative product development. 

For instance, numerous patents for advanced catheter designs have been filed by leading firms like Tata Medical Center, indicating a competitive landscape that aims to improve patient safety.This technology improvement not only boosts the efficacy of treatment but also encourages hospitals to use these devices more extensively.

**Increasing Healthcare Expenditure**

Growing healthcare expenditure in India is a vital driver for the India Central Venous Catheter Market Industry. The Government of India has announced a significant increase in healthcare spending, aiming to allocate around 2.5% of its Gross Domestic Product towards health by 2025. 

This increase will translate into higher investments in medical devices, including central venous catheters, thus accelerating their adoption across healthcare setups. As healthcare facilities enhance their infrastructure and patient care capabilities, the demand for advanced medical devices is expected to keep rising.

**Growing Number of Surgical Procedures**

The rising number of surgical procedures, both elective and emergency, in India is contributing to the expansion of the India Central Venous Catheter Market Industry. According to the National Health Authority, there has been a 30% increase in elective surgical procedures over the past few years. 

As surgeries often require central venous access for fluid management and medication delivery, this trend is stimulating the demand for central venous catheters.Major hospitals, like Apollo Hospitals, report a surge in their surgical volumes, further endorsing the upward trajectory of catheter utilization in clinical settings.

**India Central Venous Catheter Market Segment Insights**

**Central Venous Catheter Market Product Type Insights**

The India Central Venous Catheter Market is segmented into numerous product types, notably including Non-tunneled Catheters and Tunneled Catheters. This segmentation reflects the diverse requirements of healthcare facilities in India, addressing various clinical needs and patient demographics. Non-tunneled Catheters serve a critical role in acute settings, providing swift access to the central venous system for patients requiring short-term intravenous therapy, such as in emergency departments and intensive care units. 

The ability to quickly establish venous access makes this product type significant in urgent medical scenarios, facilitating essential treatments like fluid resuscitation and antibiotic administration, which is crucial for managing severe infections prevalent in the Indian healthcare landscape.Conversely, Tunneled Catheters are particularly vital for patients requiring long-term venous access, such as those undergoing repeated chemotherapy or long-term antibiotic therapy. 

Their design allows for easier maintenance and reduced risk of infection, making them an essential choice for outpatient management and chronic conditions. The use of Tunneled Catheters aligns with the growing trend of outpatient care in India, driven by the increasing prevalence of chronic diseases and the necessity for extended treatment regimens. 

This segment reflects a shift towards more efficient operational practices in healthcare facilities, catering to patients' needs for longer duration therapies while optimizing resource utilization. The India Central Venous Catheter Market data indicates a shift in preference towards these products due to their associated benefits in patient care and outcomes.As hospitals and healthcare centers in India strive to enhance patient safety and treatment effectiveness, the demand for both Non-tunneled and Tunneled Catheters is expected to grow. 

However, challenges such as infection control remain pertinent, emphasizing the need for healthcare professionals to ensure stringent protocols in catheter placement and maintenance. Furthermore, advancements within the India Central Venous Catheter Market industry, such as innovations in catheter materials and designs, aim to reduce complications and enhance patient experiences. 

Overall, the product type segmentation highlights the dynamic nature of the market, with each catheter type addressing distinct clinical scenarios that underscore both the growth drivers and the evolving landscape of patient care in India.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**Central Venous Catheter Market Property Insights**

The Property segment of the India Central Venous Catheter Market showcases the increasing demand for effective solutions in patient care, particularly in the context of the growing healthcare sector in India. The market shows considerable growth, driven by the rising incidence of chronic diseases and the expansion of healthcare facilities. Among the types of catheters, Antimicrobial Catheters gain significant attention due to their role in reducing the risk of catheter-associated infections, a major concern in medical settings.

The growing awareness among healthcare professionals about the importance of infection control propels the preference for these advanced catheters.On the other hand, Non-Antimicrobial Catheters continue to have a substantial presence as they offer cost-effective solutions for basic clinical applications. 

Others in the segment include innovative catheter technologies that cater to specific patient needs. The demand for personalized medical devices is gradually increasing, reflecting the broader trend of tailored patient care in India. The expansion of hospital infrastructure, along with government initiatives aimed at improving healthcare access, enables a favorable environment for the growth of the India Central Venous Catheter Market.Overall, the market segmentation reveals diverse opportunities influenced by technological advancements and evolving healthcare requirements in the country.

**Central Venous Catheter Market Design Insights**

The India Central Venous Catheter Market, specifically within the Design segment, encompasses various catheter designs crucial for diverse patient needs in medical procedures. The segment is primarily characterized by Multi Lumen, Double Lumen, and Single Lumen designs, each serving distinct purposes in clinical settings. Multi Lumen catheters are widely appreciated for their versatility, capable of accommodating multiple therapies simultaneously, thus enhancing patient care efficiency. 

Double Lumen designs offer significant utility for hemodynamic monitoring and therapy, while Single Lumen catheters are widely used for less complex cases, providing straightforward access with minimal complications.The rising incidence of chronic diseases and a growing geriatric population in India drive the need for these catheter designs. Furthermore, advancements in catheter technology, such as bio-compatibility and infection prevention features, are enhancing the market's appeal. 

The increasing emphasis on effective healthcare systems fuels the demand for these catheter designs, as they play a vital role in patient management and treatment protocols across healthcare settings. The market is also boosting the India Central Venous Catheter Market revenue through continuous innovation and the introduction of products tailored to specific clinical applications.

**Central Venous Catheter Market Composition Insights**

The India Central Venous Catheter Market has shown a promising trajectory, particularly within the Composition segment. This segment can be broadly categorized into materials such as Polyurethane, Silicone, and others, each playing a crucial role in the functionality and effectiveness of central venous catheters. Polyurethane catheters are typically favored for their superior strength and biocompatibility, making them ideal for long-term use, while Silicone catheters are recognized for their flexibility and resistance to kinking, which is essential for maintaining blood flow.Other materials also contribute to the diversity of options available, addressing various patient needs and clinical scenarios. 

The growing focus on patient safety, alongside advancements in materials technology, has driven significant improvements in catheter design and performance, catering to the increasing demand for effective intravenous therapy in India. Furthermore, with the healthcare system in India progressively focused on enhancing patient outcomes, the evolution of these materials is expected to foster market growth. The rising incidence of chronic diseases and procedures requiring central venous access further emphasizes the importance of the Composition segment in catering to healthcare providers and patients alike, ultimately shaping the India Central Venous Catheter Market landscape.

**India Central Venous Catheter Market Key Players and Competitive Insights**

The India Central Venous Catheter Market is characterized by a competitive landscape that has evolved in recent years, resulting from the increasing demand for minimally invasive medical procedures and advancements in healthcare technology. As hospitals and healthcare facilities focus on improving patient outcomes and enhancing treatment protocols, the choice of products in the central venous catheter segment has become essential. The rising prevalence of chronic diseases, an increase in surgical procedures, and the growing number of patients requiring outpatient services further amplify the competition among manufacturers. 

Companies in this space are innovating continuously to introduce new designs and materials that enhance safety, ease of use, and patient comfort while adhering to stringent regulatory standards. This dynamic environment presents both challenges and opportunities for stakeholders aiming to capture market share through differentiated products and strategic partnerships.

Halyard Health is a notable player in the India Central Venous Catheter Market, recognized for its commitment to quality and innovation. The company focuses on providing high-performance catheters designed to reduce the risk of complications associated with intravascular access. Halyard Health emphasizes the importance of safety features in its products, which cater to the needs of healthcare professionals and patients alike. Their market presence is bolstered by an established distribution network and strong relationships with healthcare providers across India.

With a focus on elevating healthcare standards, Halyard Health utilizes state-of-the-art manufacturing processes and embraces the latest technological advancements to maintain its competitive edge. 

The company's strengths lie in its extensive product portfolio, brand recognition, and dedicated research and development efforts geared toward enhancing the safety and efficacy of its central venous catheters.Boston Scientific is another prominent participant in the India Central Venous Catheter Market, known for its innovative approach and diverse product offerings. The company delivers a range of catheter solutions aimed at improving procedural efficiency and patient safety. 

Boston Scientific's strength in the market derives from its ability to provide technologically advanced catheters that facilitate better clinical outcomes, with designs that address common complications associated with central venous access. The company's commitment to research and development allows it to introduce cutting-edge technology in catheter design, positioning it as a leader in a competitive landscape. Boston Scientific has also been engaging in strategic mergers and acquisitions to enhance its market position and expand its product portfolio. 

This strategy enables the company to offer complementary therapies and services, thus reinforcing its brand presence in India and enhancing its capability to meet the growing demands of healthcare providers and patients in the region.

**Key Companies in the India Central Venous Catheter Market Include:**

**India Central Venous Catheter Market Industry Developments**

The India Central Venous Catheter Market has witnessed significant developments in recent months. The market growth is driven by increasing healthcare expenditure and a rise in chronic diseases requiring long-term vascular access. In September 2023, Halyard Health launched an advanced central venous catheter aimed at enhancing patient safety and ensuring better outcomes. 

Additionally, the market has seen competitive advancements from Boston Scientific and Teleflex, both releasing new products with innovative designs to improve insertion techniques. Current affairs highlight regulatory efforts by the Government of India to ensure compliance with medical device standards, fostering a safe environment for increasing market penetration. 

Over the past two years, Eagle Health and Vygon have expanded operations within India, enhancing their distribution networks to cater to the growing demand. Furthermore, Cardinal Health and Medtronic have each reported notable growth in market valuation, positively impacting their strategies in the region. 

In August 2022, a notable acquisition took place when Terumo acquired NIPRO's vascular access segment, enhancing its portfolio in the Indian market. This aligns with the growing trend of mergers aimed at increasing capabilities and market share in the Central Venous Catheter segment.

**India Central Venous Catheter Market Segmentation Insights**

**Central Venous Catheter Market Product Type Outlook**

**Central Venous Catheter Market Property Outlook**

**Central Venous Catheter Market Design Outlook**

**Central Venous Catheter Market Composition Outlook**

- Polyurethane
- Silicone

## Market Drivers

### Rising Geriatric Population

The increasing geriatric population in India is a significant driver for the central venous-catheter market. As the elderly population grows, so does the prevalence of age-related health issues that often require long-term medical care. Data suggests that by 2030, the number of individuals aged 60 and above in India will exceed 300 million, creating a substantial demand for effective healthcare solutions. Central venous catheters are essential for managing chronic conditions in this demographic, facilitating treatments such as chemotherapy and long-term medication administration. Consequently, healthcare providers are likely to invest more in these catheters to cater to the needs of the aging population, thereby propelling market growth.

### Expansion of Healthcare Infrastructure

India's healthcare infrastructure is undergoing substantial expansion, which is likely to bolster the central venous-catheter market. The government has been investing heavily in healthcare facilities, aiming to improve access to quality medical services across urban and rural areas. Recent reports indicate that healthcare expenditure in India is projected to reach $370 billion by 2025, reflecting a commitment to enhancing medical services. This expansion includes the establishment of new hospitals and clinics, which are increasingly equipped with advanced medical technologies, including central venous catheters. As more healthcare facilities become operational, the demand for these catheters is expected to rise, driven by the need for efficient patient management and treatment protocols.

### Increasing Prevalence of Lifestyle Diseases

The rising incidence of lifestyle-related diseases in India, such as diabetes and hypertension, is driving the demand for the central venous-catheter market. As these conditions often require long-term treatment and monitoring, healthcare providers are increasingly utilizing central venous catheters for effective management. According to recent data, approximately 30% of the Indian population is affected by lifestyle diseases, necessitating advanced medical interventions. This trend indicates a growing need for reliable vascular access solutions, which central venous catheters provide. The healthcare sector is adapting to these challenges by investing in better catheter technologies, thereby enhancing patient care and outcomes. Consequently, the central venous-catheter market is expected to expand significantly as healthcare facilities strive to meet the needs of this patient demographic.

### Government Initiatives for Healthcare Improvement

The Indian government is actively implementing initiatives aimed at improving healthcare access and quality, which is likely to impact the central venous-catheter market positively. Programs such as Ayushman Bharat are designed to provide affordable healthcare services to millions of citizens, thereby increasing the demand for various medical devices, including central venous catheters. With a focus on enhancing healthcare delivery systems, the government is encouraging the adoption of advanced medical technologies in hospitals and clinics. This push for modernization is expected to create a favorable environment for the central venous-catheter market, as healthcare facilities seek to comply with new standards and improve patient care.

### Growing Awareness of Advanced Medical Technologies

There is a notable increase in awareness regarding advanced medical technologies among healthcare professionals and patients in India. This growing awareness is positively influencing the central venous-catheter market, as practitioners recognize the benefits of using these devices for various medical procedures. Educational initiatives and training programs are being implemented to familiarize healthcare providers with the latest catheter technologies, which can enhance patient outcomes. Furthermore, the market is witnessing a shift towards the adoption of innovative catheter designs that minimize complications and improve safety. As a result, the central venous-catheter market is likely to experience growth as healthcare professionals become more adept at utilizing these technologies in clinical settings.

## Future Outlook

The [Central Venous Catheter Market](https://www.marketresearchfuture.com/reports/central-venous-catheter-market-19206) central venous-catheter market in India is projected to grow at a 7.41% CAGR from 2025 to 2035, driven by increasing healthcare investments, rising chronic diseases, and technological advancements.

**New opportunities:**

- Development of advanced antimicrobial catheters to reduce infection rates. Expansion of telehealth services for remote catheter management. Partnerships with hospitals for integrated catheter supply solutions.

By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare needs.

## Segment Insights

### By Product Type: Non-tunneled Catheters (Largest) vs. Tunneled Catheters (Fastest-Growing)

In the India central venous-catheter market, Non-tunneled Catheters currently hold a larger market share, favored for their quick and easy placement in emergency situations. Their straightforward design appeals to healthcare providers aiming for immediate access, particularly in critical care settings. Conversely, Tunneled Catheters are gaining traction, primarily due to their long-term utility in patients requiring extended intravenous therapy. They offer a more secure and less invasive option for prolonged access, which is increasingly prioritizing patient comfort and safety. The growth trends for Tunneled Catheters are propelled by advancements in catheter design and materials, enabling reduced risk of infection and increased patient satisfaction. Additionally, the rising prevalence of chronic diseases and the growing elderly population are driving demand for long-term solutions, making Tunneled Catheters the fastest-growing segment. Healthcare facilities are keenly adopting these devices, establishing them as a key preference among practitioners for ongoing therapy.

Non-tunneled Catheters (Dominant) vs. Tunneled Catheters (Emerging)

Non-tunneled Catheters stand as the dominant choice within the India central venous-catheter market, especially in acute care settings where immediate vascular access is critical. Their rapid deployment reduces wait times for patients requiring urgent treatment. In contrast, Tunneled Catheters, while emerging, offer significant advantages for long-term therapies, such as those needed for chemotherapy or prolonged antibiotic administration. They are designed to minimize infection risks and improve patient experience by being placed under the skin, which makes them less visible and easier to maintain. The trend towards early discharge from hospitals is supporting their adoption, positioning Tunneled Catheters as an appealing alternative for outpatient care.

### By Property: Non-Antimicrobial Catheters (Largest) vs. Antimicrobial Catheters (Fastest-Growing)

In the India central venous-catheter market, the distribution of market share among the segment values reveals that Non-Antimicrobial Catheters hold the largest share as healthcare providers often prefer them for their cost-effectiveness and usability. Antimicrobial Catheters, while currently holding a smaller share, are rapidly gaining traction due to their ability to reduce infection risks significantly, thereby attracting attention from hospitals focused on improving patient outcomes. The growth trends in this segment indicate a notable shift towards Antimicrobial Catheters, pushed by increasing awareness of healthcare-associated infections and a rising emphasis on patient safety. This trend is further accelerated by technological advancements that enhance the performance and effectiveness of these catheters. As a result, manufacturers are increasingly investing in R&D to innovate and expand their product offerings within this growing segment.

Non-Antimicrobial Catheters (Dominant) vs. Antimicrobial Catheters (Emerging)

Non-Antimicrobial Catheters dominate the market due to their established reliability and lower cost, making them the go-to choice for many medical institutions. They are commonly used in various clinical settings where the risk of infection is manageable. Conversely, Antimicrobial Catheters, positioned as an emerging option, are increasingly adopted because they incorporate materials that help in minimizing the risks associated with catheter-related infections. The contrasting characteristics of these catheters highlight the current market dynamics, where the former is favored for economic reasons, while the latter is gaining prominence due to heightened healthcare standards and infection control protocols.

### By Design: Multi Lumen (Largest) vs. Double Lumen (Fastest-Growing)

In the India central venous-catheter market, the segment distribution showcases Multi Lumen catheters as the largest segment, owing to their versatility and extensive applications in complex medical procedures. This segment holds a significant portion of the market share, primarily driven by their preferred use in hospitals and specific patient management protocols. On the other hand, Double Lumen catheters are emerging as the fastest-growing segment, reflecting an increasing demand due to their effectiveness in providing simultaneous infusion and blood sampling capabilities, which aligns with evolving healthcare practices. Growth trends in this segment are fueled by advancements in catheter technology and the ongoing demand for minimally invasive procedures. The healthcare sector's focus on enhancing patient outcomes while reducing the duration of hospital stays is propelling innovation in catheter designs. Additionally, the increasing prevalence of chronic ailments necessitates more effective and efficient venous access solutions, amplifying the role of Double Lumen catheters in the evolving landscape of the India central venous-catheter market.

Multi Lumen (Dominant) vs. Double Lumen (Emerging)

Multi Lumen catheters dominate the India central venous-catheter market due to their high adaptability and capability to manage multiple therapies simultaneously. Their design caters to various clinical needs, allowing healthcare professionals to deliver fluids, administer medications, and draw blood without the need for multiple access points. This versatility is essential for critically ill patients requiring complex treatment regimens. Conversely, Double Lumen catheters are emerging as an innovative choice in the market, appealing to medical facilities seeking efficient solutions for concurrent therapies such as blood transfusions and intravenous treatments. Their growing popularity reflects a shift towards more tailored healthcare solutions that prioritize patient safety and procedural efficiency, positioning them as a valuable asset in modern medical practices.

### By Composition: Polyurethane (Largest) vs. Silicone (Fastest-Growing)

The market share distribution in the composition segment of the India central venous-catheter market is led by polyurethane, which holds a significant portion due to its favorable properties like biocompatibility and chemical resistance. Silicone follows, gaining increased traction as healthcare providers recognize its advantages such as flexibility and reduced risk of infection. Other materials, while present, have a smaller share and are primarily used in niche applications that don’t dominate the overall market dynamics. In terms of growth trends, the polyurethane segment is expected to maintain its dominance as manufacturers continue to innovate and enhance product offerings. In contrast, silicone is projected to be the fastest-growing component, primarily driven by rising demand for safer and more effective medical devices. Factors such as increasing healthcare expenditures and advancements in catheter technology are likely to propel growth across the composition spectrum.

Composition: Polyurethane (Dominant) vs. Silicone (Emerging)

Polyurethane is a dominant material in the catheter market, favored for its exceptional durability, biocompatibility, and resistance to various chemicals. It plays a crucial role in enhancing the performance and safety of central venous catheters, making it a preferred choice among clinicians. Meanwhile, silicone is emerging as a key material, recognized for its flexibility and reduced trauma during insertion, which significantly lowers infection risks. As awareness of its benefits grows, silicone is gaining acceptance, particularly in pediatric and long-term venous access applications. Both materials indicate distinct market positions, with polyurethane leading in market share while silicone is anticipated to show robust growth amidst evolving healthcare demands.

## Competitive Benchmarking

The central venous-catheter market in India is characterized by a dynamic competitive landscape, driven by increasing healthcare demands and advancements in medical technology. Key players such as Bard (US), Medtronic (US), and Teleflex (US) are at the forefront, each adopting distinct strategies to enhance their market presence. Bard (US) focuses on innovation, particularly in developing advanced catheter designs that minimize infection risks, while Medtronic (US) emphasizes digital transformation, integrating smart technologies into their products to improve patient outcomes. Teleflex (US) is actively pursuing regional expansion, aiming to penetrate underserved markets through strategic partnerships and localized manufacturing, thereby shaping a competitive environment that prioritizes innovation and accessibility. The market structure appears moderately fragmented, with several players vying for market share. Key business tactics include localizing manufacturing to reduce costs and optimize supply chains, which is crucial in a price-sensitive market like India. The collective influence of these major companies fosters a competitive atmosphere where innovation and operational efficiency are paramount, allowing them to respond effectively to evolving healthcare needs. In October 2025, Bard (US) announced the launch of a new line of antimicrobial central venous catheters designed to significantly reduce the risk of catheter-related bloodstream infections. This strategic move not only reinforces Bard's commitment to patient safety but also positions the company as a leader in infection prevention, potentially increasing its market share in a highly competitive sector. The introduction of these products aligns with the growing demand for safer medical devices in India. In September 2025, Medtronic (US) unveiled a partnership with a leading Indian healthcare provider to implement a telehealth platform that integrates their central venous-catheter management systems. This initiative is indicative of Medtronic's strategy to leverage digital health solutions, enhancing patient monitoring and care continuity. Such partnerships may facilitate broader adoption of advanced medical technologies, thereby improving patient outcomes and solidifying Medtronic's market position. In August 2025, Teleflex (US) expanded its manufacturing capabilities in India by establishing a new facility dedicated to the production of central venous catheters. This expansion is a strategic response to the increasing demand for high-quality medical devices in the region. By localizing production, Teleflex aims to enhance supply chain efficiency and reduce lead times, which could provide a competitive edge in a rapidly evolving market. As of November 2025, current trends in the central venous-catheter market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI) into product development. Strategic alliances among key players are shaping the landscape, fostering innovation and enhancing product offerings. The competitive differentiation is likely to evolve from traditional price-based competition towards a focus on technological advancements, supply chain reliability, and sustainable practices, indicating a shift towards a more sophisticated and value-driven market.

## Recent News & Developments

The India Central Venous Catheter Market has witnessed significant developments in recent months. The market growth is driven by increasing healthcare expenditure and a rise in chronic diseases requiring long-term vascular access. In September 2023, Halyard Health launched an advanced central venous catheter aimed at enhancing patient safety and ensuring better outcomes. 

Additionally, the market has seen competitive advancements from Boston Scientific and Teleflex, both releasing new products with innovative designs to improve insertion techniques. Current affairs highlight regulatory efforts by the Government of India to ensure compliance with medical device standards, fostering a safe environment for increasing market penetration. 

Over the past two years, Eagle Health and Vygon have expanded operations within India, enhancing their distribution networks to cater to the growing demand. Furthermore, Cardinal Health and Medtronic have each reported notable growth in market valuation, positively impacting their strategies in the region. 

In August 2022, a notable acquisition took place when Terumo acquired NIPRO's vascular access segment, enhancing its portfolio in the Indian market. This aligns with the growing trend of mergers aimed at increasing capabilities and market share in the Central Venous Catheter segment.

## Report Scope

| India MARKET SIZE 2024 | 66.91(USD Million) |
| --- | --- |
| India MARKET SIZE 2025 | 71.87(USD Million) |
| India MARKET SIZE 2035 | 146.93(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.41% (2024 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Bard (US), Medtronic (US), Boston Scientific (US), Teleflex (US), Smiths Medical (US), Vygon (FR), Nipro (JP), Fresenius Kabi (DE), Cook Medical (US) |
| Segments Covered | Product Type, Property, Design, Composition |
| Key Market Opportunities In India | Integration of advanced materials and technologies enhances safety and efficacy in the central venous-catheter market. |
| Key Market Dynamics In India | Rising demand for central venous catheters driven by advancements in medical technology and increasing patient care needs. |
| Countries Covered | India |

## Frequently Asked Questions

**Q: What is the current valuation of the India central venous-catheter market as of 2024?**
A: The market valuation was $66.91 Million in 2024.

**Q: What is the projected market size for the India central venous-catheter market by 2035?**
A: The projected valuation for 2035 is $146.93 Million.

**Q: What is the expected CAGR for the India central venous-catheter market during the forecast period 2025 - 2035?**
A: The expected CAGR is 7.41% during the forecast period 2025 - 2035.

**Q: Which product type segment had the highest valuation in 2024?**
A: The Tunneled Catheters segment had a valuation of $81.93 Million in 2024.

**Q: How do antimicrobial catheters compare to non-antimicrobial catheters in terms of market valuation?**
A: In 2024, non-antimicrobial catheters were valued at $66.0 Million, while antimicrobial catheters were valued at $60.0 Million.

**Q: What are the leading companies in the India central venous-catheter market?**
A: Key players include Bard, Medtronic, Boston Scientific, Teleflex, and Smiths Medical.

**Q: What is the market valuation for multi-lumen catheters in 2024?**
A: The market valuation for multi-lumen catheters was $45.0 Million in 2024.

**Q: What composition segment had the highest valuation in 2024?**
A: The Polyurethane segment had a valuation of $66.0 Million in 2024.

**Q: What is the valuation range for tunneled catheters from 2024 to 2035?**
A: The valuation for tunneled catheters ranges from $36.91 Million in 2024 to an anticipated higher figure by 2035.

**Q: What is the expected growth trend for the India central venous-catheter market?**
A: The market is expected to grow steadily, reaching $146.93 Million by 2035.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/india-central-venous-catheter-market-52475*